With the coronavirus still wreaking havoc, vaccine stocks are in the spotlight.
To date, Gilead has noted preliminary results of a COVID-19 vaccine trial “showed...
Telehealth has become one of the biggest beneficiaries of the COVID-19 story.
All as health officials and governments strongly urge folks to limit face to...